SCHEMBL16677004

SCHEMBL16677004

[N-]=[N+]=NCC(CN=[N+]=[N-])C(N)=O

nearest known ligand 0.50

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 1/20 0.31
▸ CA2 P00918 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15398290 0.78 CHRM1 (0.33) —
SCHEMBL14252461 0.76 CPB2 (0.31) —
SCHEMBL19038578 0.73 — —
SCHEMBL17404777 0.71 CA1 (0.38) CA1CA2
SCHEMBL25317082 0.70 CA2 (0.58) CA1CA2
SCHEMBL13482801 0.70 — —
SCHEMBL13539959 0.70 — —
SCHEMBL15525400 0.70 — —
SCHEMBL16684312 0.69 — —
Hydrochloric Acid SCHEMBL23923852 0.68 PTGS1 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2225213-B1 TRIAZOLE-SUBSTITUTED ARYLAMIDE DERIVATIVES AND THEIR USE AS P2X3 AND /OR P2X2/3 PURINERGIC RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2015-04-29 — — EP disclosed
Send feedback